Search Details

Word: stocking (lookup in dictionary) (lookup stats)
Dates: during 2000-2000
Sort By: most recent first (reverse)


Usage:

...more than two years old, say--and you'll hear strange new words like consolidation, restructuring, streamlining, even profitability. "The downturn in the 'stupid' economy is going to precipitate a flight to quality," says Kyle Shannon, co-founder of agency.com a business-support site that lost employees as its stock went from $98 to $17 in seven months. "I can't wait, frankly. I'm so excited...

Author: /time Magazine | Title: Is This The End.com? | 7/3/2000 | See Source »

...last market tank [April's NASDAQ collapse], I could have retired, bought three houses and my dream boat, and had $150,000 a year in interest to live on. Now I'm back where I started," says a senior engineer at a West Coast Web-services company, whose stock was briefly worth $9 million and is currently underwater. That means it has sunk beneath the price at which he originally bought...

Author: /time Magazine | Title: Is This The End.com? | 7/3/2000 | See Source »

...colleagues, and he recognized that more controversy could overshadow a historic moment in biomedicine. Beyond that, he'd taken a beating in the marketplace. After a joint declaration by Clinton and British Prime Minister Tony Blair in March that all genomic information should be free, the value of Celera stock plummeted from $189 a share...

Author: /time Magazine | Title: The Race Is Over | 7/3/2000 | See Source »

...National Institutes of Health to begin his great gene chase, he turned almost overnight from a hardscrabble government scientist with $2,000 in the bank into a yacht- and sports car-owning multimillionaire who threw Gatsby-like parties (last year's income: $560,000, not counting options on Celera stock that were worth, at last week's closing price of $125.25, nearly $351 million). And by declaring his intention to sequence the entire human genome in only a fraction of the time (three years) and at a much lower cost ($200 million) than government-sponsored scientists had originally said...

Author: /time Magazine | Title: The Race Is Over | 7/3/2000 | See Source »

Having signed up five major pharmaceutical houses as well as Vanderbilt University, Venter says Celera has jumped ahead of all its rivals, with revenue doubling every year. Celera's stock has gyrated wildly from $15 a share to more than $320 and down to $50 in the space of a year, so Wall Street obviously can't make up its mind about the company. But, says Venter, "our business model is working terrifically." He expects profitability in another couple of years...

Author: /time Magazine | Title: The Race Is Over | 7/3/2000 | See Source »

First | Previous | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | Next | Last